Regencell Bioscience Holdings Limited

NasdaqCM:RGC

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🏥 Hospitals & Clinics

💊 Pharmaceuticals

💻 Telehealth

Location

Hong Kong

Market Cap

USD 7.29 B

Share Price

USD 14.75

Avg Daily Volume

3,111,760

Change (1 day)

-10.98%

Change (1 year)

321.43%

Change (YTD)

198.58%

Regencell Bioscience Holdings Limited Accounts Payable for the year ending June 30, 2023: USD 0.00

Regencell Bioscience Holdings Limited Accounts Payable is USD 0.00 for the year ending June 30, 2023. Accounts payable are amounts owed by the company to suppliers or vendors for goods or services received but not yet paid.

Regencell Bioscience Holdings Limited Accounts Payable for the year ending June 30, 2022 was USD 0.00.

Competitors

AbbVie Inc.

USD 192.45

ABBV

-2.55 -1.31%

Novo Nordisk A/S

USD 68.61

NOVO-B.CO

-2.69 -3.77%

Roche Holding AG

USD 343.65

RO.SW

-5.43 -1.55%

Novartis AG

USD 120.78

NOVN.SW

-3.44 -2.77%

Abbott Laboratories

USD 132.02

ABT

-1.58 -1.18%

AstraZeneca PLC

USD 140.89

AZN.L

-3.33 -2.31%

Merck & Co., Inc.

USD 83.36

MRK

-0.66 -0.79%

Amgen Inc.

USD 295.27

AMGN

-5.10 -1.70%

Pfizer Inc.

USD 25.65

PFE

-0.13 -0.50%

Gilead Sciences, Inc.

USD 109.64

GILD

-4.90 -4.28%

Vertex Pharmaceuticals Incorporated

USD 468.85

VRTX

-10.68 -2.23%

Sanofi

USD 97.05

SAN.PA

-1.42 -1.44%

Bristol-Myers Squibb Company

USD 46.86

BMY

-1.66 -3.42%

GSK plc

USD 18.99

GSK.L

-0.75 -3.81%

Chugai Pharmaceutical Co., Ltd.

USD 46.36

4519.T

-0.52 -1.11%

CSL Limited

USD 158.31

CSL.AX

-1.36 -0.85%

Regeneron Pharmaceuticals, Inc.

USD 567.74

REGN

+7.98 1.43%

MERCK Kommanditgesellschaft auf Aktien

USD 131.84

MRK.DE

-2.06 -1.54%

Jiangsu Hengrui Medicine Co., Ltd.

USD 7.93

600276.SS

-0.09 -1.14%

Takeda Pharmaceutical Company Limited

USD 29.69

4502.T

+0.05 0.17%

Key Data

Date	Accounts Payable	Short-Term Debt	Long-Term Debt	Total Liabilities